BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8132806)

  • 1. Correction to: IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas.
    Am J Clin Pathol; 2024 Jan; 161(1):107. PubMed ID: 37991998
    [No Abstract]   [Full Text] [Related]  

  • 2. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.
    Hu S; Xu-Monette ZY; Balasubramanyam A; Manyam GC; Visco C; Tzankov A; Liu WM; Miranda RN; Zhang L; Montes-Moreno S; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Han van Krieken J; Huang Q; Huh J; Ai W; Ponzoni M; Ferreri AJ; Zhao X; Winter JN; Zhang M; Li L; Møller MB; Piris MA; Li Y; Go RS; Wu L; Medeiros LJ; Young KH
    Blood; 2013 Apr; 121(14):2715-24. PubMed ID: 23343832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD20-negative de novo diffuse large B-cell lymphoma in HIV-negative patients: a matched case-control analysis in a single institution.
    Li YJ; Li ZM; Rao HL; Xia Y; Huang HQ; Xia ZJ; Li S; Li WY; Jiang WQ
    J Transl Med; 2012 May; 10():84. PubMed ID: 22554077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30+ anaplastic large-cell lymphoma with aberrant expression of CD13: case report and review of the literature.
    Dunphy CH; Gardner LJ; Manes JL; Bee CS; Taysi K
    J Clin Lab Anal; 2000; 14(6):299-304. PubMed ID: 11138613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of CD30 expression to survival and morphology in large cell B cell lymphomas.
    Noorduyn LA; de Bruin PC; van Heerde P; van de Sandt MM; Ossenkoppele GJ; Meijer CJ
    J Clin Pathol; 1994 Jan; 47(1):33-7. PubMed ID: 8132806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphoma.
    Romaguera JE; Garcia-Foncillas J; Cabanillas F
    Leuk Lymphoma; 1995 Dec; 20(1-2):97-102. PubMed ID: 8750629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30 expression in non-Hodgkin's lymphoma.
    Piris M; Brown DC; Gatter KC; Mason DY
    Histopathology; 1990 Sep; 17(3):211-8. PubMed ID: 2173674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas.
    Haralambieva E; Pulford KA; Lamant L; Pileri S; Roncador G; Gatter KC; Delsol G; Mason DY
    Br J Haematol; 2000 Jun; 109(3):584-91. PubMed ID: 10886208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
    Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
    Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas. A clinicopathologic analysis of six cases.
    Paulli M; Rosso R; Kindl S; Boveri E; Bonoldi E; Stracca V; Motta T; Arrigoni G; Lazzarino M; Menestrina F
    Cancer; 1994 Feb; 73(3):541-9. PubMed ID: 8299075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosis.
    de Bruin PC; Noorduyn AL; van der Valk P; van Heerde P; van Diest PJ; van de Sandt MM; Ossenkoppele GJ; Meijer CJ
    Cancer; 1993 Apr; 71(8):2604-12. PubMed ID: 8453584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells.
    Schwab U; Stein H; Gerdes J; Lemke H; Kirchner H; Schaadt M; Diehl V
    Nature; 1982 Sep; 299(5878):65-7. PubMed ID: 7110326
    [No Abstract]   [Full Text] [Related]  

  • 14. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.
    Stein H; Mason DY; Gerdes J; O'Connor N; Wainscoat J; Pallesen G; Gatter K; Falini B; Delsol G; Lemke H
    Blood; 1985 Oct; 66(4):848-58. PubMed ID: 3876124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases.
    Agnarsson BA; Kadin ME
    Am J Surg Pathol; 1988 Apr; 12(4):264-74. PubMed ID: 3354752
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.